- Home
- MNKD vs NATL Comparison
MNKD vs NATL Comparison
Compare MNKD & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- NATL
- Stock Information
- Founded
- MNKD 1991
- NATL 2023
- Country
- MNKD United States
- NATL United States
- Employees
- MNKD N/A
- NATL N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- NATL
- Sector
- MNKD Health Care
- NATL
- Exchange
- MNKD Nasdaq
- NATL Nasdaq
- Market Cap
- MNKD 1.8B
- NATL 2.0B
- IPO Year
- MNKD 2004
- NATL N/A
- Fundamental
- Price
- MNKD $6.80
- NATL $29.42
- Analyst Decision
- MNKD Strong Buy
- NATL Buy
- Analyst Count
- MNKD 5
- NATL 4
- Target Price
- MNKD $8.40
- NATL $35.50
- AVG Volume (30 Days)
- MNKD 2.9M
- NATL 384.8K
- Earning Date
- MNKD 11-07-2024
- NATL 11-12-2024
- Dividend Yield
- MNKD N/A
- NATL N/A
- EPS Growth
- MNKD N/A
- NATL N/A
- EPS
- MNKD 0.08
- NATL N/A
- Revenue
- MNKD $267,200,000.00
- NATL $4,307,000,000.00
- Revenue This Year
- MNKD $46.83
- NATL $4.77
- Revenue Next Year
- MNKD $14.40
- NATL $2.62
- P/E Ratio
- MNKD $85.77
- NATL N/A
- Revenue Growth
- MNKD 51.35
- NATL 3.58
- 52 Week Low
- MNKD $3.17
- NATL $18.42
- 52 Week High
- MNKD $7.63
- NATL $35.29
- Technical
- Relative Strength Index (RSI)
- MNKD 47.15
- NATL 56.54
- Support Level
- MNKD $6.61
- NATL $28.12
- Resistance Level
- MNKD $7.44
- NATL $32.87
- Average True Range (ATR)
- MNKD 0.35
- NATL 1.30
- MACD
- MNKD -0.05
- NATL 0.29
- Stochastic Oscillator
- MNKD 18.63
- NATL 51.88
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About NATL NCR Atleos Corporation
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a global customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. They manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications & Technology.